Device Trial Radar · NCT04532580
Clinical Validation of Boneview for FDA Submission
Last checked: Nov 20, 2026Latest source record: Aug 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
480
Actual
Start
Sep 1, 2020
Primary completion
May 10, 2021
Study completion Jul 26, 2021
Sponsor
- Lead sponsor
- GleamerNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 31, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical validation is to assess comparative performances of physicians with and without the assistance of BoneView for the diagnosis of fractures on radiographs. The performances are evaluated in terms of accuracy (primary endpoint with the pair specificity/sensitivity and the secondary endpoint PPV/NPV) and in terms of time needed for diagnosis (secondary endpoint with the measurement of time on each case).
Conditions
- Fracture
Interventions
Diagnosis of fracture on X-Ray RadiographsDevice
Diagnosis of fracture on X-Ray Radiographs with and without the assistance of Boneview Software
Primary outcomes
What the sponsor says the trial is designed to measure.
- measurement of diagnosis performances via calculation of sensitivity, specificity, NPV, PPVTime frame: 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Boston Imaging Core Lab
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.